| AJNMMI Copyright © 2011-present, All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA |
Forthcoming Titles
(PDFs in this page may not be proofed yet)
Ramasamy Paulmurugan, et al: Imaging estrogen receptor in tamoxifen resistant breast cancer: exploration of new modes of receptor regulation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
David M Schuster, et al: Characterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Nandi A, Kuwabara H, et al: Integrated data analysis environment (IDAE) for neuroimaging studies with microPET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
James M Mountz, et al: Imaging biomarker assessment of early therapy response for personalized management in cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zibo Li, et al: Hepatic stellate cells (HSC)-targeted imaging and therapy for liver fibrosis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Xiankai Sun, et al: Peptoid-based PET imaging of VEGFR2 expression. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Georges El Fakhri, et al: Quantitative dynamic PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Lei Xing, et al: Investigations of dual modality X-ray and optical luminescent imaging. Am J Nucl Med Mol Imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zhenghong Lee, et al: PET imaging of hepatocellular carcinoma. Am J Nucl Med Mol Imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
W. Barry Edwards, et al: Imaging reactive oxygen species in prostate tumor xenografts. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zhaofei (Jeff) Liu, et al: Directly and indirectly 99mTc-labeled monoclonal antibody 3H11 for cancer detection. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zhaofei (Jeff) Liu, et al: Peptide-based radiopharmaceuticals for tumor targeted radionuclide therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
PD Habib Zaidi, et al: Molecular imaging technology in the era of molecular medicine. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Irina Velikyan, et al: Preparation and evaluation of a 68Ga-labelled RGD-containing octapeptide: bioditribution in Rhesus monkey. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Bradley T. Christian, et al: In vivo characteristics of a novel a4b2 nicotinic PET radioligand. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Onofre T. DeJesus, et al: Assessment of aromatic amino acid decarboxylase activity in vivo in health and disease. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Peeyush Bhargava, et al: SPECT/CT imaging acquisition, processing and display paramaters. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Xianzhong Zhang, et al: Chitosan based 99mTc agent for folate-receptor-mediated targeting. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Timothy R DeGrado, et al., Choline-PET and tumor aggressiveness phenotype. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Wawrzyniec L. Dobrucki, et al: Multimodal molecular imaging of angiogenesis in cardiovascular complications. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Edward E. Graves, et al: Molecular imaging of radiation response: Challenges and opportunities. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Chin-Tu Chen, et al: Integrative multi-modality molecular imaging: hybrid imaging devices. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chin-Tu Chen, et al: Integrative multi-modality molecular imaging: probes. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chin-Tu Chen, et al: Multi-modality molecular image co-registration, reconstruction, and analysis. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Kimberly Kelly, et al: Comparison of SPECT and PET imaging for plectin-1 imaging of pancreatic cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Tracy R. McKnight, et al: Molecular imaging of p53-mediated therapeutic response in gliomas. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Feng Cao, et al: Molecular Imaging of stem cell in therapeutic angiogenesis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jinming Gao, et al: Theranostic nanomedicine for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Fuyou Li, et al: lanthanide-based nanoparticles for multimodality bioimaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Edward J. Delikatny, et al: Imaging phospholipase activity in murine models of rheumatoid arthritis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hui Mao, Anthony W. Chan, et al: Molecular Imaging with genetically engineered MRI reporters. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Andrei Iagaru, et al: PET/CT in the Management of Sarcomas. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jin Xie, et al: Composite nanoparticles for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Scott Perlman, et al: Clinical Molecular Imaging with PET Agents Other than 18F-FDG. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Weibo Cai, et al: Non-invasive imaging of iPS Cells. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Frank Wuest, et al: 4-[18F]Fluoro-N-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide ([18F]-SA): A suitable click chemistry building block for 18F labeling of peptides, proteins and oligonucleotides. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Joseph M. Backer, et al: Imaging and targeting angiogenesis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Kai Chen, et al: Application of NGR-containing peptides for tumor imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jason P. Holland, et al: Beyond molecular imaging: annotating oncogene activity with PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Vladimir Tolmachev, et al: Scaffold proteins, a new class of targeting agents for molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Dongfeng Pan, et al: A novel near-infrared fluorescence imaging probe for in vivo neutrophil tracking. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Dongfeng Pan, et al: Synthesis and Evaluation of a Tumor-targeting SPECT/Fluorescence Dual-imaging agent: PC-1001. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mian Alauddin, et al: Novel probes for PET imaging of cellular proliferation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zdravka O. Medarova, et al: Nanoparticles for Molecular Imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Guozheng Liu, et al: Islet cell imaging: a hundred times more difficult than ever experienced. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Henning Boecker, et al: The endorphinergic system in exercise research. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Wellington Pham, et al: Preclinical evaluation of a novel nanobeacon for imaging colorectal cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
H. Charles Manning, et al: Imaging TSPO expression in oncology. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ran C, Anna Moore A. Cherenkov radiation for in vivo imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zhonglin Liu, et al: Imaging of inflammatory response in ischemic-reperfused myocardium. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Duane J Myklejord et al., Molecular imaging of Tie-2 expression. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Kusmirek JE et al., Molecular imaging of c-Met expression. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Witte KE et al., PET imaging of pancreatic Cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hall LT, PET imaging of brain tumor. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Sandip Biswal, et al: Imaging Pain and Nociception. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jennifer Cochran, et al: Molecular imaging with disulfide-rich polypeptides. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Robin P. Choudhury, et al: Molecular imaging in acute ischemic syndromes. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Reinhard Meier, et al: Optical Imaging for Detection of Inflammation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Tarik F. Massoud, et al: Molecular Neuroimaging: Current and Future developments. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ming Zhao, et al: Whole-body imaging of irradiation-induced apoptosis using 99mTc-Duramycin. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Fabian Kiessling, et al: Nano- and microparticles for ultrasound-based diagnosis and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ilan Ziv, et al: Clinical Molecular Imaging of Apoptosis: from bench to bedside. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Arutselvan Natarajan, et al: Development of immunoreagants for novel cancer biomarker dicovery. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Jean-Luc Vanderheyden, et al: Connecting the dots: Role of chemistry and translational imaging in the future of Molecular Imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Byeong-Cheol Ahn, et al: A false positive uptakes on radioiodine whole body scan. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Evan D. Morris, et al: Imaging Neurotransmitter Dynamics with PET. A review of ntPET methods. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Yu-Shin Ding, et al: PET imaging of norepinephrine transporter: application to studies of cocaine dependence and ADHD. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Wengen Chen, et al: Molecular imaging of vulnerable atherosclerotic plaque (review). Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Omid Farokhzad,, et al: Nanotechnology in cancer therapy and imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jan Grimm, et al: Cerenkov Imaging - a new imaging modality for molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ralph P. Mason, et al: Dynamic bioluminescent imaging: an effective tool to evaluate vascular disrupting agents. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Benjamin J. Hackel, et al: Design Parameters for Molecular Imaging Agents. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Katherine A. Vallis, et al: Auger electron therapy using radioimmunoconstructs, bispecific for EGFR and DNA damage signaling proteins. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Simon Ametamey, et al: Radiosynthesis and biological evaluation of a new mGluR5 PET radioligand. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Marina Emborg, et al: Molecular imaging of animal models of cardiac neurodegeneration. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael Hofman, et al: Scintillating Imaging with Gallium-68 PET/CT: new insights from old tracers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ming-Kai Chen, et al: Optimizing imaging acquisition with minimized radiation exposure for F-18 FDG PET-CT. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ming-Kai Chen, et al: The utility of a pretherapy scan in determining I-131 radioablative dose for thyroid cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Frank Roesch, et al: Long-term molecular imaging of 90Nb-labelled monoclonal antiboides. Am J Nucl Med Mol Imagin g2017;7(x):xx-xx.
Mohsen Beheshti, et al: Imaging of prostate cancer with PET/CT using radiolabeled choline derivatives. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Lily Yang, et al: Multimodality tumor imaging for effective treatment of drug resistant cancers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Richard P. Baum, et al: Molecular imaging and radiopeptide therapy of neuroendocrine tumors. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Bart Cornelissen, et al: Auger electron therapy of cancer cells and tumor xenografts using 111In-labelled F3-peptide. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Stefano Fanti, et al: the clinical use of PET with 11C-Acetate. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jiang He, et al: Pretargeting for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Nanguang Chen, et al: Rotational probe for breast imaging with diffusive light. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jeng-Jong Hwang, et al: Therapeutic evaluation of human breast carcinoma using enolase as a molecular target with molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mohsen Beheshti, et al: Imaging of prostate cancer with PET/CT using radiolabeled choline derivatives. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Thaddeus J. Wadas, et al: Prostate cancer imaging and PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ed X. Wu, et al: Manganese-enhanced MRI of visual components and pathways. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
S. Sendhil Velan, et al: Multimodal imaging of brown fat in metabolic disease. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Henry K.F. Mak et al., Diffusion tensor imaging and MR spectroscopy at 3-tesla in neuropychiatric systemic lupus erythematoisus. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Henry K.F. Mak et al., Quantitative MR spectroscopy in aging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Bin Liu, et al: Conjugated Polymer Nanoparticles for Targeted Fluorescence Imaging of Cancer Cells. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yan Zhang, et al: Imaging of proteases over-expressed in tumor microenvironment. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Wing-tak Wong, et al: Peptide-labeled AuNPs as a NIR/MR/Micro-CT contrast agent for targeted imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Eyal Mishani, et al: PET myocardial perfusion imaging agents- the new generation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ralf Schirrmacher, et al: Radioactively labeled proteins in nuclear imaging: A new generation of imaging agents. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Sean Carlin, et al: Sequential registered dynamic MRI and 18F-FMISO PET following VEGFR blockade. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
David RJ Owen, et al: Imaging the translocator protein. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Alexander K. Converse, et al: Regional cerebral blood flow response to amphetamine in rat measured by [17F]fluoromethane PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jogesh Mukherjee, et al: Fallypride PET for Brain Dopamine Receptor Imaging- What have we learnt? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Seo Y, et al: Translation multipinhole-multiaperture SPECT. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hideo Saji, et al: Radiolabelled probes for atherosclerotic plaque imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jamal Zweit et al, Targeted Multi-Signal Nano-Probes: Implications for multi-modality molecular Imaging and nano-Therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Gary L. Griffiths et al., The Imaging Probe Development Center at the National Institutes of Health: a core chemistry facility supplying molecular probes to diverse bioscientists since 2007. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jun Toyohara, et al: Longitudinal small-animal PET imaging of 11C-4DST in turpentine-inducel inflamatiory tissue. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Shuanglong Liu, et al: Novel 18F-labeled aliphatic probe for melanoma imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Barbara Fischer, et al: PET/CT for radiotherapy planning or PET/MRI - current status and future perspectives. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Orit Jacobson, et al: Carbon-11 labeled benzimidazole inhibitor of TIE-2 and VEGFR-2 receptor tyrosine kinases as a molecular imaging agent for angiogenesis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Sangeeta Ray, et al: Radiometals for imaging and therapy of prostate cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Guo-Jun Zhang, et al: The functional roles of CXCR4 in triple-negative breast cancer using in vivo bioluminescence imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
James R. Mansfield, et al: Automated segmentation and quantitation of in-vivo fluorescence images using machine-learning. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Kuniaki Ogasawara, et al: Prediction of cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis using preoperative 123I-iomazenil SPECT imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Eric O. Aboagye, et al: Imaging with choline radiotracers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jae Sung Lee, Sujin Kim, Dong Soo Lee: Multiple linear analysis for reversible and irreversible radiotracers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Orhan K. Oz, et al: Molecular and functional imaging of bone. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ronald Boellaard, et al: Quantification and simplified measure in PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Imene Zerizer, et al: Role of FDG PET/CT in radiotherapy of gynaecological malignancies: Where are we now? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Susan L. Deutscher, et al: In vivo selection of rapidly excreted phage-displayed peptides. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Philip W. Miller, et al: Recent developments in microfluidic methods for high speed radiolabelling in PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Susanne Keiding, et al: Functional molecular imaging of the liver. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yumin Zhang, et al: Imaging with radiolabeled antibodies for the development of antibody-based therapeutics. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yongjun Yan, et al: Molecular imaging probes targeting cancer vasculatur. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zheng-Rong Lu, et al: Synthesis and evaluation of a targeted contrast agent for MR cancer molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Felix M. Mottaghy, et al: Molecular imaging of therapy response with 18F-FLT-PET following cyclophosphamide and mTOR inhibition. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Thomas WD, Chuanbin Mao: Phage display enabled molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Sangyong Jon, et al: High-affinity peptide based neclear imaging of cancers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Andreas H. Jacobs, et al: imaging shRNA interference in gliomas. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael L. Goris, et al: Observation of global decreased brain FDG uptake, unrelated to primary neurological disease. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Young-tae Chang, et al: Novel multimodal nanoparticle sensors. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Farouc Jaffer, et al: Intravascular molecular imaging: progress towards the cardiac catheterization laboratory. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Rong Zhou, et al: Using imaging techniques to evaluate the survival and function of novel cardiomyocyte progenitor cells. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Stephen H Thorne, et al: Imaging of Biological Cancer Therapies. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ornella E. Rimoldi, et al: Non-invasive evaluation of ischemic heart disease in women. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Albert J. Sinusas, et al: Nuclear imaging in peripheral arterial disease. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Anthony F. Shields, et al: FLT PET imaging, an update. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael Sørensen, et al: Molecular imaging of regional metabolic function of the liver. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Gang Huang, et al: Diagnostic value of (11)C-choline positron emission tomography in patients with PSA relapse after radical treatment of prostate cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Henry Engler, et al: Imaging astrocytosis with PET in Creutzfeldt-Jakob disease: Case report with histopathological findings. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Keon Wook Kang, et al: In vivo nano-molecular imaging of cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Luca Giovanella, et al: Role of preoperative 18FDG-PET/CT in patients with thyroid nodules. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jae Sung Lee, Sujin Kim, Dong Soo Lee: Multiple linear analysis for reversible and irreversible radiotracers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Luigi Mansi, et al: The role of radiopeptides in Nuclear Medicine. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Xiao-Feng Li, et al: Hypoxia microenviroment dependent 18F-FDG uptake in macroscopic and microscopic tumors. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Joseph A. O'Donoghue, et al: Clinical studies with the tumor hypoxia PET tracer 124I-IAZGP. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
François Bénard, et al: Overexpression of peptide receptors as targets for PET or SPECT radiopharmaceuticals: a breast cancer tissue microarray study. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mikako Ogawa, et al: Molecular imaging probes for atherosclerosis imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mathieu Hatt, et al: Potential impact of improved functional volume delineation algorithms in clinical practice. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Soonhag Kim, et al: In vivo imaging of microRNA124a-independent neuronal differentiation of human G2 neural stem cells. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
David M Schuster, et al: Synthetic amino acid imaging of primary prostate carcinoma: A pilot study. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Masahiro Fujita, et al: PET imaging of intracellular signal transduction systems. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Tapan K. Nayak, et al: Molecular imaging of EGFR. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jason L. Dearling, et al: Use of PET and DW-MRI in the early detection of the response of neuroblastoma tumors to chemotherapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Roger R Fulton, et al: Evaluation of a patient motion correction technique for paediatric PET/CT imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ryogo Minamimoto, et al: 99mTc-aprotinin for imaging of amyloidosis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Christopher J. Endres, et al: The role of parameter coupling in quantitative PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hans-Jürgen Biersack, et al: Lu-177 DOTATE therapy in NET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
John O Prior, et al: Peritoneal carcinomatosis due to ovarian cancer: Comparison between MDCT, MRI and F-18-FDG PET/CT). Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Paolo Ciana, et al: Imaging estrogen receptor activity during neoplastic transformation of the mouse breast. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Elba Cristina Etchebehere, et al: THE role of PET/CT in radioablation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yi-Hwa Liu, et al: New methods of image quantification for hybrid cardiac imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ludwig G. Strauss, et al: Parametric imaging with dPET-CT in oncology. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yun Zhou, et al: Recent advances in quantitative dynamic PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Lars Stelter, et al: Evaluation of Arginine deiminase therapy in malignant melanoma using molecular imaging strategies. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jae Min Jeong, et al: F-18 labeled radipharmaceuticals. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mingfeng Bai, et al: In vivo type 2 cannabinoid receptor targeted near infrared fluorescence imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
René A Tio, at al: Myocardial perfusion reserve: is it worth measuring? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hancheng Cai, et al: PET probes for reporter gene HSV1-tk imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Steve Y Cho, et al: FDG PET imaging of treatment response and prognosis in pediatric Hodgkin Lymphoma. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ming-Rong Zhang, et al: Positron Emission Tomography Imaging of Inflammation in Peripheral Organs with Translocator Protein (18KDa) Radioligand. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yongjian Liu, et al: Radionuclide-Based Molecular Imaging for Pulmonary Applications. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jonathan F Lovell, et al: Folate-receptor targeting for fluorescence-switching nanoparticles. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Samer Ezziddin, et al: Bone metastases in GEP NET: Response and long-term outcome after PRRT from a follow-up analysis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ciprian Catana, et al: MR-assisted PET motion correction improves PET data quantification in simultaneous PET/MR brain imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chenjie Xu, et al: Stem cell tracking with smart nanoparticles. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Paco E. Bravo, et al: Clinical significance of delayed enhancement on cardiac magnetic resonance confined to the right ventricular junctional segments in hypertrophic cardiomyopathy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Tan To Cheung, et al: The role of 11C-Acetate and 18F-FDG PET/CT on the management of hepatocellular carcinoma. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Dexing Zeng, et al: Click chemistry and applications in the preparation of PET agents. Am J Nucl Med Mol Imaging2017;7(x):xx-xx.
Tan To Cheung, et al: The prognostic value of 11C-Acetate and 18F-FDG PET/CT on patient with hepatocelluar carcinoma treated by hepatectomy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Gang Liu, et al: Functional magnetic nanoparticles for cardiovascular molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Gianmario Sambuceti, et al: Bone marrow imaging in blood diseases. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
David L. Morse, et al: Targeting the cell-surface for cancer imaging” or alternatively “Cell surface marker discovery for development of cancer targeted agents. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Rebecca A Dumont, et al: Novel preclinical applications for PET/MR. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Alan Jackson, et al: Molecular imaging of modifications of the blood/brain barrier in cerebral tumours. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael Lin, et al: Should FDG PET-CT be used routinely in staging colorectal cancers? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Pablo R. Ros, et al: PET/MR in a clinical environment in the US: lessons learned. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chandrasekhar Bal, et al: Role of 68Ga-Bisphsphonates in Skeletal Scintigraphy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Simona Ben-Haim, et al: The correlation between baseline folate receptor expression measured by 99mTc-etarfolatide (99mTc-EC20) scans and response to treatment with Vintafolide in patients with advanced cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Silvia Morbelli, et al: Cognitive reserve: implications for brain 18F-FDG and amyloid PET imaging. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Andrew C. Larson, et al: Nuclear Imaging Methods for Localization of Y-90 Microspheres Following Radioembolization. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Anne Roivainen, et al: 15O-Water and 68Ga-DOTA PET imaging for assessment of blood flow and vascular permeability in a rat model of inflammation – comparison with ultrasound imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael R. Lewis, et al: Copper-64-Labeled PNA-Peptide Conjugates Selectively Localize in BCL2-Positive Tumors in Mouse Models of B-cell Lymphoma/Leukemia. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Matthias Eder, et al: Fluorescein conjugates as tools to follow the intracellular distribution of the PET tracer Glu-urea-Lys-HBED-CC. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Andrew J Saykin, st al: TSPO PET as a biomarker for brain immune status. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Stefan Reuter, et al: 18F-fluoride positron emission tomography-based assessment of cisplatin nephrotoxicity in mice. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Olof Eriksson, et al: Imaging of the endocrine pancreas: retrospective evaluation of clinically available neuroendocrine Positron Emission Tomography markers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Olaf Prante, et al: Synthesis and in vivo Evaluation of an 18F-labeled glycoconjugate of PD156707 for imaging ET(A) receptor expression in thyroid carcinoma by positron emission tomography. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michelle L James, et al: Positron Emission Tomography Imaging of Alzheimer's Disease Mouse Models. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Robert Hobbs, et al: Radioimmunotherapy of orbital lymphoma: 3D-RD dosimetry for eye, lens, optical nerve and tumor. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Guillem Pratx, et al: Cell microscopy with radioactive dyes. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chongzhao Ran, et al: Spectral unmixing and its application in Molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Adriana Alexandre S Tavares, et al: Lysophospholipid receptors: novel targets for brain imaging. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Daniel LJ Thorek, et al: Functional imaging of prostate cancer in mouse models. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Stavroula Sofou, et al: Evaluation of the therapeutic potential of vasculature-targeting liposomes loaded with alpha-particle emitters. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Orazio Schillaci, et al: The role of 18FDG positron emission tomography in the follow-up of liver tumors treated with 90Yttrium radioembolization. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Richard Southworth, et al: Can we agree upon a unified approach for preclinical FDG PET imaging? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Philipp Heusch, et al: PET/MRI: an overview of current evidence in oncology. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jens Siveke, et al: Imaging modalities for early tumor response evaluation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mike M. Sathekge, et al: Molecular Imaging of Tuberculosis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jingyi Chen, et al: Plasmonic nanoparticles for molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
(The journal is now accepting manuscript submissions. Please go to Information for Authors to prepare your manuscript for
submission to American Journal of Nuclear Medicine and Molecular Imaging.)
(PDFs in this page may not be proofed yet)
Ramasamy Paulmurugan, et al: Imaging estrogen receptor in tamoxifen resistant breast cancer: exploration of new modes of receptor regulation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
David M Schuster, et al: Characterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Nandi A, Kuwabara H, et al: Integrated data analysis environment (IDAE) for neuroimaging studies with microPET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
James M Mountz, et al: Imaging biomarker assessment of early therapy response for personalized management in cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zibo Li, et al: Hepatic stellate cells (HSC)-targeted imaging and therapy for liver fibrosis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Xiankai Sun, et al: Peptoid-based PET imaging of VEGFR2 expression. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Georges El Fakhri, et al: Quantitative dynamic PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Lei Xing, et al: Investigations of dual modality X-ray and optical luminescent imaging. Am J Nucl Med Mol Imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zhenghong Lee, et al: PET imaging of hepatocellular carcinoma. Am J Nucl Med Mol Imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
W. Barry Edwards, et al: Imaging reactive oxygen species in prostate tumor xenografts. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zhaofei (Jeff) Liu, et al: Directly and indirectly 99mTc-labeled monoclonal antibody 3H11 for cancer detection. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zhaofei (Jeff) Liu, et al: Peptide-based radiopharmaceuticals for tumor targeted radionuclide therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
PD Habib Zaidi, et al: Molecular imaging technology in the era of molecular medicine. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Irina Velikyan, et al: Preparation and evaluation of a 68Ga-labelled RGD-containing octapeptide: bioditribution in Rhesus monkey. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Bradley T. Christian, et al: In vivo characteristics of a novel a4b2 nicotinic PET radioligand. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Onofre T. DeJesus, et al: Assessment of aromatic amino acid decarboxylase activity in vivo in health and disease. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Peeyush Bhargava, et al: SPECT/CT imaging acquisition, processing and display paramaters. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Xianzhong Zhang, et al: Chitosan based 99mTc agent for folate-receptor-mediated targeting. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Timothy R DeGrado, et al., Choline-PET and tumor aggressiveness phenotype. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Wawrzyniec L. Dobrucki, et al: Multimodal molecular imaging of angiogenesis in cardiovascular complications. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Edward E. Graves, et al: Molecular imaging of radiation response: Challenges and opportunities. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Chin-Tu Chen, et al: Integrative multi-modality molecular imaging: hybrid imaging devices. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chin-Tu Chen, et al: Integrative multi-modality molecular imaging: probes. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chin-Tu Chen, et al: Multi-modality molecular image co-registration, reconstruction, and analysis. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Kimberly Kelly, et al: Comparison of SPECT and PET imaging for plectin-1 imaging of pancreatic cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Tracy R. McKnight, et al: Molecular imaging of p53-mediated therapeutic response in gliomas. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Feng Cao, et al: Molecular Imaging of stem cell in therapeutic angiogenesis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jinming Gao, et al: Theranostic nanomedicine for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Fuyou Li, et al: lanthanide-based nanoparticles for multimodality bioimaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Edward J. Delikatny, et al: Imaging phospholipase activity in murine models of rheumatoid arthritis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hui Mao, Anthony W. Chan, et al: Molecular Imaging with genetically engineered MRI reporters. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Andrei Iagaru, et al: PET/CT in the Management of Sarcomas. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jin Xie, et al: Composite nanoparticles for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Scott Perlman, et al: Clinical Molecular Imaging with PET Agents Other than 18F-FDG. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Weibo Cai, et al: Non-invasive imaging of iPS Cells. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Frank Wuest, et al: 4-[18F]Fluoro-N-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide ([18F]-SA): A suitable click chemistry building block for 18F labeling of peptides, proteins and oligonucleotides. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Joseph M. Backer, et al: Imaging and targeting angiogenesis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Kai Chen, et al: Application of NGR-containing peptides for tumor imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jason P. Holland, et al: Beyond molecular imaging: annotating oncogene activity with PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Vladimir Tolmachev, et al: Scaffold proteins, a new class of targeting agents for molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Dongfeng Pan, et al: A novel near-infrared fluorescence imaging probe for in vivo neutrophil tracking. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Dongfeng Pan, et al: Synthesis and Evaluation of a Tumor-targeting SPECT/Fluorescence Dual-imaging agent: PC-1001. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mian Alauddin, et al: Novel probes for PET imaging of cellular proliferation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zdravka O. Medarova, et al: Nanoparticles for Molecular Imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Guozheng Liu, et al: Islet cell imaging: a hundred times more difficult than ever experienced. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Henning Boecker, et al: The endorphinergic system in exercise research. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Wellington Pham, et al: Preclinical evaluation of a novel nanobeacon for imaging colorectal cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
H. Charles Manning, et al: Imaging TSPO expression in oncology. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ran C, Anna Moore A. Cherenkov radiation for in vivo imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zhonglin Liu, et al: Imaging of inflammatory response in ischemic-reperfused myocardium. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Duane J Myklejord et al., Molecular imaging of Tie-2 expression. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Kusmirek JE et al., Molecular imaging of c-Met expression. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Witte KE et al., PET imaging of pancreatic Cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hall LT, PET imaging of brain tumor. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Sandip Biswal, et al: Imaging Pain and Nociception. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jennifer Cochran, et al: Molecular imaging with disulfide-rich polypeptides. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Robin P. Choudhury, et al: Molecular imaging in acute ischemic syndromes. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Reinhard Meier, et al: Optical Imaging for Detection of Inflammation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Tarik F. Massoud, et al: Molecular Neuroimaging: Current and Future developments. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ming Zhao, et al: Whole-body imaging of irradiation-induced apoptosis using 99mTc-Duramycin. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Fabian Kiessling, et al: Nano- and microparticles for ultrasound-based diagnosis and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ilan Ziv, et al: Clinical Molecular Imaging of Apoptosis: from bench to bedside. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Arutselvan Natarajan, et al: Development of immunoreagants for novel cancer biomarker dicovery. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Jean-Luc Vanderheyden, et al: Connecting the dots: Role of chemistry and translational imaging in the future of Molecular Imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Byeong-Cheol Ahn, et al: A false positive uptakes on radioiodine whole body scan. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Evan D. Morris, et al: Imaging Neurotransmitter Dynamics with PET. A review of ntPET methods. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Yu-Shin Ding, et al: PET imaging of norepinephrine transporter: application to studies of cocaine dependence and ADHD. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Wengen Chen, et al: Molecular imaging of vulnerable atherosclerotic plaque (review). Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Omid Farokhzad,, et al: Nanotechnology in cancer therapy and imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jan Grimm, et al: Cerenkov Imaging - a new imaging modality for molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ralph P. Mason, et al: Dynamic bioluminescent imaging: an effective tool to evaluate vascular disrupting agents. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Benjamin J. Hackel, et al: Design Parameters for Molecular Imaging Agents. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Katherine A. Vallis, et al: Auger electron therapy using radioimmunoconstructs, bispecific for EGFR and DNA damage signaling proteins. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Simon Ametamey, et al: Radiosynthesis and biological evaluation of a new mGluR5 PET radioligand. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Marina Emborg, et al: Molecular imaging of animal models of cardiac neurodegeneration. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael Hofman, et al: Scintillating Imaging with Gallium-68 PET/CT: new insights from old tracers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ming-Kai Chen, et al: Optimizing imaging acquisition with minimized radiation exposure for F-18 FDG PET-CT. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ming-Kai Chen, et al: The utility of a pretherapy scan in determining I-131 radioablative dose for thyroid cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Frank Roesch, et al: Long-term molecular imaging of 90Nb-labelled monoclonal antiboides. Am J Nucl Med Mol Imagin g2017;7(x):xx-xx.
Mohsen Beheshti, et al: Imaging of prostate cancer with PET/CT using radiolabeled choline derivatives. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Lily Yang, et al: Multimodality tumor imaging for effective treatment of drug resistant cancers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Richard P. Baum, et al: Molecular imaging and radiopeptide therapy of neuroendocrine tumors. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Bart Cornelissen, et al: Auger electron therapy of cancer cells and tumor xenografts using 111In-labelled F3-peptide. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Stefano Fanti, et al: the clinical use of PET with 11C-Acetate. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jiang He, et al: Pretargeting for cancer imaging and therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Nanguang Chen, et al: Rotational probe for breast imaging with diffusive light. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jeng-Jong Hwang, et al: Therapeutic evaluation of human breast carcinoma using enolase as a molecular target with molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mohsen Beheshti, et al: Imaging of prostate cancer with PET/CT using radiolabeled choline derivatives. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Thaddeus J. Wadas, et al: Prostate cancer imaging and PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ed X. Wu, et al: Manganese-enhanced MRI of visual components and pathways. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
S. Sendhil Velan, et al: Multimodal imaging of brown fat in metabolic disease. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Henry K.F. Mak et al., Diffusion tensor imaging and MR spectroscopy at 3-tesla in neuropychiatric systemic lupus erythematoisus. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Henry K.F. Mak et al., Quantitative MR spectroscopy in aging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Bin Liu, et al: Conjugated Polymer Nanoparticles for Targeted Fluorescence Imaging of Cancer Cells. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yan Zhang, et al: Imaging of proteases over-expressed in tumor microenvironment. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Wing-tak Wong, et al: Peptide-labeled AuNPs as a NIR/MR/Micro-CT contrast agent for targeted imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Eyal Mishani, et al: PET myocardial perfusion imaging agents- the new generation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ralf Schirrmacher, et al: Radioactively labeled proteins in nuclear imaging: A new generation of imaging agents. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Sean Carlin, et al: Sequential registered dynamic MRI and 18F-FMISO PET following VEGFR blockade. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
David RJ Owen, et al: Imaging the translocator protein. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Alexander K. Converse, et al: Regional cerebral blood flow response to amphetamine in rat measured by [17F]fluoromethane PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jogesh Mukherjee, et al: Fallypride PET for Brain Dopamine Receptor Imaging- What have we learnt? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Seo Y, et al: Translation multipinhole-multiaperture SPECT. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hideo Saji, et al: Radiolabelled probes for atherosclerotic plaque imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jamal Zweit et al, Targeted Multi-Signal Nano-Probes: Implications for multi-modality molecular Imaging and nano-Therapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Gary L. Griffiths et al., The Imaging Probe Development Center at the National Institutes of Health: a core chemistry facility supplying molecular probes to diverse bioscientists since 2007. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jun Toyohara, et al: Longitudinal small-animal PET imaging of 11C-4DST in turpentine-inducel inflamatiory tissue. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Shuanglong Liu, et al: Novel 18F-labeled aliphatic probe for melanoma imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Barbara Fischer, et al: PET/CT for radiotherapy planning or PET/MRI - current status and future perspectives. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Orit Jacobson, et al: Carbon-11 labeled benzimidazole inhibitor of TIE-2 and VEGFR-2 receptor tyrosine kinases as a molecular imaging agent for angiogenesis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Sangeeta Ray, et al: Radiometals for imaging and therapy of prostate cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Guo-Jun Zhang, et al: The functional roles of CXCR4 in triple-negative breast cancer using in vivo bioluminescence imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
James R. Mansfield, et al: Automated segmentation and quantitation of in-vivo fluorescence images using machine-learning. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Kuniaki Ogasawara, et al: Prediction of cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis using preoperative 123I-iomazenil SPECT imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Eric O. Aboagye, et al: Imaging with choline radiotracers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jae Sung Lee, Sujin Kim, Dong Soo Lee: Multiple linear analysis for reversible and irreversible radiotracers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Orhan K. Oz, et al: Molecular and functional imaging of bone. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ronald Boellaard, et al: Quantification and simplified measure in PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Imene Zerizer, et al: Role of FDG PET/CT in radiotherapy of gynaecological malignancies: Where are we now? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Susan L. Deutscher, et al: In vivo selection of rapidly excreted phage-displayed peptides. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Philip W. Miller, et al: Recent developments in microfluidic methods for high speed radiolabelling in PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Susanne Keiding, et al: Functional molecular imaging of the liver. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yumin Zhang, et al: Imaging with radiolabeled antibodies for the development of antibody-based therapeutics. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yongjun Yan, et al: Molecular imaging probes targeting cancer vasculatur. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Zheng-Rong Lu, et al: Synthesis and evaluation of a targeted contrast agent for MR cancer molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Felix M. Mottaghy, et al: Molecular imaging of therapy response with 18F-FLT-PET following cyclophosphamide and mTOR inhibition. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Thomas WD, Chuanbin Mao: Phage display enabled molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Sangyong Jon, et al: High-affinity peptide based neclear imaging of cancers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Andreas H. Jacobs, et al: imaging shRNA interference in gliomas. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael L. Goris, et al: Observation of global decreased brain FDG uptake, unrelated to primary neurological disease. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Young-tae Chang, et al: Novel multimodal nanoparticle sensors. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Farouc Jaffer, et al: Intravascular molecular imaging: progress towards the cardiac catheterization laboratory. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Rong Zhou, et al: Using imaging techniques to evaluate the survival and function of novel cardiomyocyte progenitor cells. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Stephen H Thorne, et al: Imaging of Biological Cancer Therapies. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ornella E. Rimoldi, et al: Non-invasive evaluation of ischemic heart disease in women. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Albert J. Sinusas, et al: Nuclear imaging in peripheral arterial disease. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Anthony F. Shields, et al: FLT PET imaging, an update. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael Sørensen, et al: Molecular imaging of regional metabolic function of the liver. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Gang Huang, et al: Diagnostic value of (11)C-choline positron emission tomography in patients with PSA relapse after radical treatment of prostate cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Henry Engler, et al: Imaging astrocytosis with PET in Creutzfeldt-Jakob disease: Case report with histopathological findings. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Keon Wook Kang, et al: In vivo nano-molecular imaging of cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Luca Giovanella, et al: Role of preoperative 18FDG-PET/CT in patients with thyroid nodules. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jae Sung Lee, Sujin Kim, Dong Soo Lee: Multiple linear analysis for reversible and irreversible radiotracers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Luigi Mansi, et al: The role of radiopeptides in Nuclear Medicine. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Xiao-Feng Li, et al: Hypoxia microenviroment dependent 18F-FDG uptake in macroscopic and microscopic tumors. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Joseph A. O'Donoghue, et al: Clinical studies with the tumor hypoxia PET tracer 124I-IAZGP. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
François Bénard, et al: Overexpression of peptide receptors as targets for PET or SPECT radiopharmaceuticals: a breast cancer tissue microarray study. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mikako Ogawa, et al: Molecular imaging probes for atherosclerosis imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mathieu Hatt, et al: Potential impact of improved functional volume delineation algorithms in clinical practice. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Soonhag Kim, et al: In vivo imaging of microRNA124a-independent neuronal differentiation of human G2 neural stem cells. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
David M Schuster, et al: Synthetic amino acid imaging of primary prostate carcinoma: A pilot study. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Masahiro Fujita, et al: PET imaging of intracellular signal transduction systems. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Tapan K. Nayak, et al: Molecular imaging of EGFR. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jason L. Dearling, et al: Use of PET and DW-MRI in the early detection of the response of neuroblastoma tumors to chemotherapy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Roger R Fulton, et al: Evaluation of a patient motion correction technique for paediatric PET/CT imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ryogo Minamimoto, et al: 99mTc-aprotinin for imaging of amyloidosis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Christopher J. Endres, et al: The role of parameter coupling in quantitative PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hans-Jürgen Biersack, et al: Lu-177 DOTATE therapy in NET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
John O Prior, et al: Peritoneal carcinomatosis due to ovarian cancer: Comparison between MDCT, MRI and F-18-FDG PET/CT). Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Paolo Ciana, et al: Imaging estrogen receptor activity during neoplastic transformation of the mouse breast. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Elba Cristina Etchebehere, et al: THE role of PET/CT in radioablation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yi-Hwa Liu, et al: New methods of image quantification for hybrid cardiac imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ludwig G. Strauss, et al: Parametric imaging with dPET-CT in oncology. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yun Zhou, et al: Recent advances in quantitative dynamic PET. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Lars Stelter, et al: Evaluation of Arginine deiminase therapy in malignant melanoma using molecular imaging strategies. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jae Min Jeong, et al: F-18 labeled radipharmaceuticals. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mingfeng Bai, et al: In vivo type 2 cannabinoid receptor targeted near infrared fluorescence imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
René A Tio, at al: Myocardial perfusion reserve: is it worth measuring? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Hancheng Cai, et al: PET probes for reporter gene HSV1-tk imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Steve Y Cho, et al: FDG PET imaging of treatment response and prognosis in pediatric Hodgkin Lymphoma. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ming-Rong Zhang, et al: Positron Emission Tomography Imaging of Inflammation in Peripheral Organs with Translocator Protein (18KDa) Radioligand. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Yongjian Liu, et al: Radionuclide-Based Molecular Imaging for Pulmonary Applications. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jonathan F Lovell, et al: Folate-receptor targeting for fluorescence-switching nanoparticles. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Samer Ezziddin, et al: Bone metastases in GEP NET: Response and long-term outcome after PRRT from a follow-up analysis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Ciprian Catana, et al: MR-assisted PET motion correction improves PET data quantification in simultaneous PET/MR brain imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chenjie Xu, et al: Stem cell tracking with smart nanoparticles. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Paco E. Bravo, et al: Clinical significance of delayed enhancement on cardiac magnetic resonance confined to the right ventricular junctional segments in hypertrophic cardiomyopathy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Tan To Cheung, et al: The role of 11C-Acetate and 18F-FDG PET/CT on the management of hepatocellular carcinoma. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Dexing Zeng, et al: Click chemistry and applications in the preparation of PET agents. Am J Nucl Med Mol Imaging2017;7(x):xx-xx.
Tan To Cheung, et al: The prognostic value of 11C-Acetate and 18F-FDG PET/CT on patient with hepatocelluar carcinoma treated by hepatectomy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Gang Liu, et al: Functional magnetic nanoparticles for cardiovascular molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Gianmario Sambuceti, et al: Bone marrow imaging in blood diseases. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
David L. Morse, et al: Targeting the cell-surface for cancer imaging” or alternatively “Cell surface marker discovery for development of cancer targeted agents. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Rebecca A Dumont, et al: Novel preclinical applications for PET/MR. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Alan Jackson, et al: Molecular imaging of modifications of the blood/brain barrier in cerebral tumours. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael Lin, et al: Should FDG PET-CT be used routinely in staging colorectal cancers? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Pablo R. Ros, et al: PET/MR in a clinical environment in the US: lessons learned. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chandrasekhar Bal, et al: Role of 68Ga-Bisphsphonates in Skeletal Scintigraphy. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Simona Ben-Haim, et al: The correlation between baseline folate receptor expression measured by 99mTc-etarfolatide (99mTc-EC20) scans and response to treatment with Vintafolide in patients with advanced cancer. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Silvia Morbelli, et al: Cognitive reserve: implications for brain 18F-FDG and amyloid PET imaging. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Andrew C. Larson, et al: Nuclear Imaging Methods for Localization of Y-90 Microspheres Following Radioembolization. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Anne Roivainen, et al: 15O-Water and 68Ga-DOTA PET imaging for assessment of blood flow and vascular permeability in a rat model of inflammation – comparison with ultrasound imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michael R. Lewis, et al: Copper-64-Labeled PNA-Peptide Conjugates Selectively Localize in BCL2-Positive Tumors in Mouse Models of B-cell Lymphoma/Leukemia. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Matthias Eder, et al: Fluorescein conjugates as tools to follow the intracellular distribution of the PET tracer Glu-urea-Lys-HBED-CC. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Andrew J Saykin, st al: TSPO PET as a biomarker for brain immune status. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Stefan Reuter, et al: 18F-fluoride positron emission tomography-based assessment of cisplatin nephrotoxicity in mice. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Olof Eriksson, et al: Imaging of the endocrine pancreas: retrospective evaluation of clinically available neuroendocrine Positron Emission Tomography markers. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Olaf Prante, et al: Synthesis and in vivo Evaluation of an 18F-labeled glycoconjugate of PD156707 for imaging ET(A) receptor expression in thyroid carcinoma by positron emission tomography. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Michelle L James, et al: Positron Emission Tomography Imaging of Alzheimer's Disease Mouse Models. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Robert Hobbs, et al: Radioimmunotherapy of orbital lymphoma: 3D-RD dosimetry for eye, lens, optical nerve and tumor. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Guillem Pratx, et al: Cell microscopy with radioactive dyes. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Chongzhao Ran, et al: Spectral unmixing and its application in Molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Adriana Alexandre S Tavares, et al: Lysophospholipid receptors: novel targets for brain imaging. Am J Nucl Med Mol Imaging 2014;4(x):xx-xx.
Daniel LJ Thorek, et al: Functional imaging of prostate cancer in mouse models. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Stavroula Sofou, et al: Evaluation of the therapeutic potential of vasculature-targeting liposomes loaded with alpha-particle emitters. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Orazio Schillaci, et al: The role of 18FDG positron emission tomography in the follow-up of liver tumors treated with 90Yttrium radioembolization. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Richard Southworth, et al: Can we agree upon a unified approach for preclinical FDG PET imaging? Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Philipp Heusch, et al: PET/MRI: an overview of current evidence in oncology. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jens Siveke, et al: Imaging modalities for early tumor response evaluation. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Mike M. Sathekge, et al: Molecular Imaging of Tuberculosis. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
Jingyi Chen, et al: Plasmonic nanoparticles for molecular imaging. Am J Nucl Med Mol Imaging 2019;9(x):xx-xx.
(The journal is now accepting manuscript submissions. Please go to Information for Authors to prepare your manuscript for
submission to American Journal of Nuclear Medicine and Molecular Imaging.)
 |  |  |  |  |  |  |